Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabian Finkelmeier

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
European Journal of Cancer (Oxford, England : 1990)|December 20, 2016
Reply to the Letter to the Editor concerning 'High levels of the soluble programmed death-ligand identify hepatocellular carcinoma patients with a poor prognosis'Fabian Finkelmeier, Oliver Waidmann
Gastrointestinal Endoscopy|May 22, 2016
ResponseFabian Finkelmeier, Jörg G Albert
Expert Review of Anticancer Therapy|October 12, 2018
Nivolumab for the treatment of hepatocellular carcinomaFabian Finkelmeier, Oliver Waidmann, Joerg Trojan
Journal of Hepatocellular Carcinoma|February 26, 2024
Systemic Drugs for Hepatocellular Carcinoma: What Do Recent Clinical Trials Reveal About Sequencing and the Emerging Complexities of Clinical Decisions?Vera Himmelsbach, Christine Koch, Jörg Trojan, et al.
Parasitology Research|January 6, 2019
Correction to: Myiasis in humans-a global case report evaluation and literature analysisVictoria Bernhardt, Fabian Finkelmeier, Marcel A Verhoff, et al.
Parasitology Research|November 21, 2018
Myiasis in humans-a global case report evaluation and literature analysisVictoria Bernhardt, Fabian Finkelmeier, Marcel A Verhoff, et al.
Plos One|June 30, 2015
Low 25-Hydroxyvitamin D Levels Are Associated with Infections and Mortality in Patients with CirrhosisFabian Finkelmeier, Bernd Kronenberger, Stefan Zeuzem, et al.
Plos One|October 1, 2019
Blast vacuolization in AML patients indicates adverse-risk AML and is associated with impaired survival after intensive induction chemotherapyOlivier Ballo, Jan Stratmann, Hubert Serve, et al.
Cureus|February 16, 2026
Long-Term Outcomes of Transarterial Chemoembolization for Intrahepatic Cholangiocarcinoma: Overall Survival and Tumor ResponseThomas J Vogl, Anna Hillebrand, John Bielfeldt, et al.
La Radiologia Medica|May 5, 2026
High-power microwave ablation with preablation transarterial chemoembolization enhances ablation zone stability in patients with liver malignanciesThomas J Vogl, Daniel M Dahm, Leon V Stein, et al.
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
European Journal of Cancer (Oxford, England : 1990)|December 20, 2016
Reply to the Letter to the Editor concerning 'High levels of the soluble programmed death-ligand identify hepatocellular carcinoma patients with a poor prognosis'Fabian Finkelmeier, Oliver Waidmann
Gastrointestinal Endoscopy|May 22, 2016
ResponseFabian Finkelmeier, Jörg G Albert
Expert Review of Anticancer Therapy|October 12, 2018
Nivolumab for the treatment of hepatocellular carcinomaFabian Finkelmeier, Oliver Waidmann, Joerg Trojan
Journal of Hepatocellular Carcinoma|February 26, 2024
Systemic Drugs for Hepatocellular Carcinoma: What Do Recent Clinical Trials Reveal About Sequencing and the Emerging Complexities of Clinical Decisions?Vera Himmelsbach, Christine Koch, Jörg Trojan, et al.
Parasitology Research|January 6, 2019
Correction to: Myiasis in humans-a global case report evaluation and literature analysisVictoria Bernhardt, Fabian Finkelmeier, Marcel A Verhoff, et al.
Parasitology Research|November 21, 2018
Myiasis in humans-a global case report evaluation and literature analysisVictoria Bernhardt, Fabian Finkelmeier, Marcel A Verhoff, et al.
Plos One|June 30, 2015
Low 25-Hydroxyvitamin D Levels Are Associated with Infections and Mortality in Patients with CirrhosisFabian Finkelmeier, Bernd Kronenberger, Stefan Zeuzem, et al.
Plos One|October 1, 2019
Blast vacuolization in AML patients indicates adverse-risk AML and is associated with impaired survival after intensive induction chemotherapyOlivier Ballo, Jan Stratmann, Hubert Serve, et al.
Cureus|February 16, 2026
Long-Term Outcomes of Transarterial Chemoembolization for Intrahepatic Cholangiocarcinoma: Overall Survival and Tumor ResponseThomas J Vogl, Anna Hillebrand, John Bielfeldt, et al.
La Radiologia Medica|May 5, 2026
High-power microwave ablation with preablation transarterial chemoembolization enhances ablation zone stability in patients with liver malignanciesThomas J Vogl, Daniel M Dahm, Leon V Stein, et al.
Pageof 13